Published in J Bone Miner Res on January 01, 2001
Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet (2005) 1.08
Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures. Calcif Tissue Int (2008) 1.08
Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev (2003) 1.04
Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study. Neurobiol Aging (2007) 1.00
Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia. Haematologica (2009) 0.94
Genetic markers of osteoarticular disorders: facts and hopes. Arthritis Res (2001) 0.91
Estrogen receptor-alpha variants increase risk of Alzheimer's disease in women with Down syndrome. Dement Geriatr Cogn Disord (2008) 0.89
Assessment of linkage and association of 13 genetic loci with bone mineral density. J Bone Miner Metab (2006) 0.88
Association of estrogen receptor alpha and collagen type I alpha 1 gene polymorphisms with bone mineral density in postmenopausal women. Osteoporos Int (2010) 0.85
The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? J Bone Miner Metab (2009) 0.81
Distinct association of gene polymorphisms of estrogen receptor and vitamin D receptor with lumbar spondylosis in post-menopausal women. Eur Spine J (2005) 0.80
Association between ER-α polymorphisms and bone mineral density in patients with Turner syndrome subjected to estroprogestagen treatment--a pilot study. J Bone Miner Metab (2011) 0.80
Relationship of volumetric bone mineral density and structural parameters with ERalpha gene polymorphisms. Calcif Tissue Int (2007) 0.79
Genetics of bone loss in rheumatoid arthritis--role of vitamin D receptor polymorphisms. Rheumatology (Oxford) (2009) 0.79
PvuII and XbaI polymorphisms of estrogen receptor-α and the results of estroprogestagen therapy in girls with functional hypothalamic amenorrhea - preliminary study. Arch Med Sci (2012) 0.79
Gene expression studies of osteoporosis: implications for microarray research. Osteoporos Int (2003) 0.77
Association of estrogen receptor alpha gene microsatellite polymorphism with annual changes in bone mineral density in Korean women with hormone replacement therapy. J Bone Miner Metab (2005) 0.77
Bone mass pharmacogenetics and ethnic health implications. Clin Cases Miner Bone Metab (2007) 0.76
Prevalence of ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms in Brazilian breast cancer-unaffected women. Braz J Med Biol Res (2012) 0.76
Estrogen receptor alpha gene analysis in osteoporosis and familial osteoporosis. Osteoporos Int (2004) 0.75
Estrogen receptor α (ESR1) IVS1-397T>C polymorphism lowers risk of fracture. Int J Clin Exp Med (2015) 0.75
Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet (1985) 3.82
Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum (2003) 2.94
Cytokinin and gibberellin-like activity in the spring sap of trees. Experientia (1968) 2.80
Mineralisation defects with pamidronate therapy for Paget's disease. Lancet (1993) 2.76
Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas (2009) 2.74
Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med (1998) 2.64
Management of Paget's disease of bone. Rheumatology (Oxford) (2004) 2.60
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med (1998) 2.42
Guidelines on the management of Paget's disease of bone. Bone (2002) 2.34
Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study. BMJ (1992) 2.27
Metabolism of [H]Gibberellin A(20) in Light- and Dark-grown Tobacco Callus Cultures. Plant Physiol (1976) 2.25
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet (1996) 2.23
Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet (1985) 2.15
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet (2000) 2.13
A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest (2001) 1.98
Incidence of distal forearm fracture in British men and women. Osteoporos Int (2001) 1.79
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Association of polymorphism at the type I collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum (1999) 1.70
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res (2000) 1.70
Health-related quality of life and radiographic vertebral fracture. Osteoporos Int (2003) 1.70
Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health? Am J Clin Nutr (2000) 1.63
Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int (2000) 1.62
The distribution, determinants, and clinical correlates of vertebral osteophytosis: a population based survey. J Rheumatol (1999) 1.60
Nitric oxide and bone. Immunology (2001) 1.60
Drought-induced increases in abscisic Acid levels in the root apex of sunflower. Plant Physiol (1985) 1.59
Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J Bone Miner Res (1991) 1.57
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood (1996) 1.56
Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol (1995) 1.55
Randomized trial of osteoporosis screening. Use of hormone replacement therapy and quality-of-life results. Arch Intern Med (1997) 1.53
Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) (1986) 1.49
Recruitment methods for screening programmes: trial of an improved method within a regional osteoporosis study. BMJ (1993) 1.49
Predicting a second hip fracture. J Clin Densitom (1999) 1.47
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J (Clin Res Ed) (1986) 1.47
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol (1995) 1.45
Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone (2003) 1.44
A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: a novel mechanism of oncogene de-regulation. Oncogene (2000) 1.43
Bone mineral density measurements: are they worth while? J R Soc Med (1996) 1.39
Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax (1992) 1.39
Radial bone mineral density and estimated rates of change in normal Scottish women: assessment by peripheral quantitative computed tomography. Calcif Tissue Int (1999) 1.38
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci (Lond) (1984) 1.36
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int (2012) 1.36
Nutritional influences on bone mineral density: a cross-sectional study in premenopausal women. Am J Clin Nutr (1997) 1.35
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas (2013) 1.34
Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis (1995) 1.34
Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology (2001) 1.32
Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study. Rheumatology (Oxford) (2004) 1.32
Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest (1991) 1.28
Mothers and daughters menopausal ages: is there a link? Eur J Obstet Gynecol Reprod Biol (1997) 1.27
Growth of C57BL/6 mice and the material and mechanical properties of cortical bone from the tibia. Calcif Tissue Int (2004) 1.27
Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res (1998) 1.25
Relationship of urinary pyridinium crosslinks to disease extent and activity in osteoarthritis. Br J Rheumatol (1994) 1.24
Investigations into the possible regulation of negative gravitropic curvature in intact Avena sativa plants and in isolated stem segments by ethylene and gibberellins. Physiol Plant (1985) 1.24
Radiographic features of lumbar disc degeneration and bone mineral density in men and women. Ann Rheum Dis (2005) 1.22
A method for assessment of the shape of the proximal femur and its relationship to osteoporotic hip fracture. Osteoporos Int (2003) 1.21
Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20
Role of genetic factors in the pathogenesis of osteoporosis. J Endocrinol (2000) 1.18
Factors associated with onset of menopause in women aged 45-49. Maturitas (1994) 1.18
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int (2001) 1.17
A rapid method for the extraction and analysis of abscisic Acid from plant tissue. Plant Physiol (1980) 1.17
Is short vertebral height always an osteoporotic fracture? The Osteoporosis and Ultrasound Study (OPUS). Bone (2007) 1.15
Quantitative ultrasound or clinical risk factors--which best identifies women at risk of osteoporosis? Br J Radiol (2000) 1.15
Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone (1996) 1.14
Biology of the mononuclear phagocyte system of the central nervous system and HIV infection. J Leukoc Biol (1994) 1.14
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet (2001) 1.14
Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements. Br J Rheumatol (1986) 1.14
Bone density and bone turnover in patients with osteoarthritis and osteoporosis. J Rheumatol (1999) 1.13
Collagen Ialpha1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: the OFELY study. J Bone Miner Res (1998) 1.13
Abnormal growth factor and cytokine expression in Dupuytren's contracture. J Clin Pathol (1993) 1.13
RNA and protein synthesis; prerequisites of red light-induced gibberellin synthesis. Nature (1968) 1.12
Bone loss associated with a high fibre weight reduction diet in postmenopausal women. Eur J Clin Nutr (1994) 1.12
Management of male osteoporosis: report of the UK Consensus Group. QJM (1998) 1.10
Back pain, disability, and radiographic vertebral fracture in European women: a prospective study. Osteoporos Int (2004) 1.10
Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol (1997) 1.09
The economics of osteoporosis and its prevention. A review. Pharmacoeconomics (1997) 1.09
Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone (1997) 1.08
Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol (1997) 1.08
Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood (1994) 1.08
Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent. Biochem Biophys Res Commun (1998) 1.08
Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet (2005) 1.08
Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia (1998) 1.08
Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum (2001) 1.07
Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. J R Coll Physicians Lond (1996) 1.07
A negative search for a paramyxoviral etiology of Paget's disease of bone: molecular, immunological, and ultrastructural studies in UK patients. J Bone Miner Res (2000) 1.07